The biology of photodynamic therapy

J V Moore1, C M West, C Whitehurst

  • 1Laser Oncology Programme, Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.

Insights

Photodynamic therapy (PDT) uses light and photosensitizers to treat tissues. This review explores PDT

Area of Science:

  • Biochemistry
  • Oncology
  • Medical Imaging

Background:

  • Photodynamic therapy (PDT) involves non-toxic photosensitizing chemicals activated by visible light.
  • PDT targets subcellular, cellular, and tissue/tumour interactions.
  • The endothelium and vasculature are potential primary targets in PDT.

Purpose of the Study:

  • To review the interactions in photodynamic therapy (PDT).
  • To discuss the role of endothelium/vasculature as a primary target in PDT.
  • To highlight biochemical manipulation opportunities for optimizing PDT outcomes.

Main Methods:

  • Review of existing literature on photodynamic therapy (PDT).
  • Analysis of subcellular, cellular, and tissue/tumour interactions.
  • Discussion of biochemical pathways and imaging modalities.

Main Results:

  • PDT involves interactions at multiple biological levels.
  • Endothelium/vasculature may be a key target for PDT.
  • Biochemical modulation can influence PDT efficacy.
  • Tumour destruction by PDT is amenable to imaging.

Conclusions:

  • PDT is a versatile therapeutic modality with complex biological interactions.
  • Targeting endothelium/vasculature is a promising strategy in PDT.
  • Biochemical manipulation offers avenues for enhancing PDT effectiveness.
  • Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) are suitable for monitoring PDT outcomes.